ProLonged Liposomal Delivery of TLR7/8 Agonist for Enhanced Cancer Vaccine

Despite numerous studies on cancer treatment, cancer remains a challenging disease to cure, even after decades of research. In recent years, the cancer vaccine has emerged as a promising approach for cancer treatment, offering few unexpected side effects compared to existing therapies. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sehui, Park, Yeji, Kim, Jeonghun, Kim, Sohyun, Choi, Kyungmin, Kang, Taegyun, Lee, Inho, Lim, Yong Taik, Um, Soong Ho, Kim, Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538091/
https://www.ncbi.nlm.nih.gov/pubmed/37766179
http://dx.doi.org/10.3390/vaccines11091503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538091/
https://www.ncbi.nlm.nih.gov/pubmed/37766179
http://dx.doi.org/10.3390/vaccines11091503

Ejemplares similares